메뉴 건너뛰기




Volumn 60, Issue 6, 1999, Pages 366-372

Lithium augmentation fails to reduce symptoms in poorly responsive schizophrenic outpatients

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CLOZAPINE; FLUPHENAZINE DECANOATE; LITHIUM; PROPRANOLOL; RESERPINE;

EID: 0033056109     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/jcp.v60n0604     Document Type: Article
Times cited : (27)

References (47)
  • 1
    • 0037921348 scopus 로고
    • The neuroleptic-nonresponsive patient: An introduction
    • Angrist B, Schulz SC, eds. Washington, DC: American Psychiatric Press
    • Angrist B, Schulz SC. The neuroleptic-nonresponsive patient: an introduction. In: Angrist B, Schulz SC, eds. The Neuroleptic-Nonresponsive Patient: Characterization and Treatment. Washington, DC: American Psychiatric Press; 1990: xvii-xxviii
    • (1990) The Neuroleptic-nonresponsive Patient: Characterization and Treatment
    • Angrist, B.1    Schulz, S.C.2
  • 3
    • 0027178496 scopus 로고
    • Psychopharmacologic treatment of schizophrenia
    • Kane JM, Marder SR. Psychopharmacologic treatment of schizophrenia. Schizophr Bull 1993;19:287-302
    • (1993) Schizophr Bull , vol.19 , pp. 287-302
    • Kane, J.M.1    Marder, S.R.2
  • 4
    • 0011560044 scopus 로고
    • Nonresponders to neuroleptics: A distinct subtype
    • Schulz SC, Tamminga CA, eds. New York, NY: Oxford University Press
    • Schulz SC, Conley RR, Kahn EM, et al. Nonresponders to neuroleptics: a distinct subtype. In: Schulz SC, Tamminga CA, eds. Schizophrenia: Scientific Progress. New York, NY: Oxford University Press; 1989:341-350
    • (1989) Schizophrenia: Scientific Progress , pp. 341-350
    • Schulz, S.C.1    Conley, R.R.2    Kahn, E.M.3
  • 5
    • 0025978419 scopus 로고
    • National institute of mental health longitudinal study of chronic schizophrenia: Prognosis and predictors of outcome
    • Breier AF, Schreiber JL, Dyer J, et al. National Institute of Mental Health longitudinal study of chronic schizophrenia: prognosis and predictors of outcome. Arch Gen Psychiatry 1991;48:239-246
    • (1991) Arch Gen Psychiatry , vol.48 , pp. 239-246
    • Breier, A.F.1    Schreiber, J.L.2    Dyer, J.3
  • 6
    • 0026040246 scopus 로고
    • Neuroleptics and the natural course of schizophrenia
    • Wyatt RJ. Neuroleptics and the natural course of schizophrenia. Schizophr Bull 1991;17:325-351
    • (1991) Schizophr Bull , vol.17 , pp. 325-351
    • Wyatt, R.J.1
  • 7
    • 0017278835 scopus 로고
    • Recent developments in the drug treatment of schizophrenia
    • Davis JM. Recent developments in the drug treatment of schizophrenia. Am J Psychiatry 1976;133:208-214
    • (1976) Am J Psychiatry , vol.133 , pp. 208-214
    • Davis, J.M.1
  • 8
    • 0016731931 scopus 로고
    • Very high dosage versus standard dosage fluphenazine in schizophrenia: A double-blind study of non-chronic treatment-refractory patients
    • Quitkin FM, Rifkin A, Klein DF. Very high dosage versus standard dosage fluphenazine in schizophrenia: a double-blind study of non-chronic treatment-refractory patients. Arch Gen Psychiatry 1975;32:1276-1281
    • (1975) Arch Gen Psychiatry , vol.32 , pp. 1276-1281
    • Quitkin, F.M.1    Rifkin, A.2    Klein, D.F.3
  • 10
    • 0019430196 scopus 로고
    • Rapid treatment of acute psychotic symptoms with high-and low-dose haloperidol: Behavioral considerations
    • Neborsky R, Janowsky D, Munson E, et al. Rapid treatment of acute psychotic symptoms with high-and low-dose haloperidol: behavioral considerations. Arch Gen Psychiatry 1981;38:195-199
    • (1981) Arch Gen Psychiatry , vol.38 , pp. 195-199
    • Neborsky, R.1    Janowsky, D.2    Munson, E.3
  • 11
    • 0023184229 scopus 로고
    • Low and conventional-dose maintenance therapy with fluphenazine decanoate
    • Marder SR, Van Putten T, Mintz J, et al. Low and conventional-dose maintenance therapy with fluphenazine decanoate. Arch Gen Psychiatry 1987; 44:518-521
    • (1987) Arch Gen Psychiatry , vol.44 , pp. 518-521
    • Marder, S.R.1    Van Putten, T.2    Mintz, J.3
  • 13
    • 0018372191 scopus 로고
    • Combination of lithium carbonate and haloperidol in schizoaffective disorder: A controlled study
    • Biederman J, Lerner Y, Belmaker RH. Combination of lithium carbonate and haloperidol in schizoaffective disorder: a controlled study. Arch Gen Psychiatry 1979;36:327-333
    • (1979) Arch Gen Psychiatry , vol.36 , pp. 327-333
    • Biederman, J.1    Lerner, Y.2    Belmaker, R.H.3
  • 14
    • 0019460191 scopus 로고
    • Lithium combined with neuroleptics in chronic schizophrenic and schizoaffective patients
    • Carman JS, Bigelow LB, Wyatt RJ. Lithium combined with neuroleptics in chronic schizophrenic and schizoaffective patients. J Clin Psychiatry 1981;42:124-128
    • (1981) J Clin Psychiatry , vol.42 , pp. 124-128
    • Carman, J.S.1    Bigelow, L.B.2    Wyatt, R.J.3
  • 16
    • 0016830149 scopus 로고
    • A placebo-controlled study of lithium combined with neuroleptics in chronic schizophrenic patients
    • Small JG, Kellams JJ, Milstein V, et al. A placebo-controlled study of lithium combined with neuroleptics in chronic schizophrenic patients. Am J Psychiatry 1975;132:1315-1317
    • (1975) Am J Psychiatry , vol.132 , pp. 1315-1317
    • Small, J.G.1    Kellams, J.J.2    Milstein, V.3
  • 17
    • 85077805398 scopus 로고
    • Presynaptic modulators of dopamine synthesis in the treatment of chronic schizophrenia
    • Angrist B, Schulz SC, eds. Washington, DC: American Psychiatric Press
    • Berlant JL. Presynaptic modulators of dopamine synthesis in the treatment of chronic schizophrenia. In: Angrist B, Schulz SC, eds. The Neuroleptic-Nonresponsive Patient: Characterization and Treatment. Washington, DC: American Psychiatric Press; 1990:137-152
    • (1990) The Neuroleptic-nonresponsive Patient: Characterization and Treatment , pp. 137-152
    • Berlant, J.L.1
  • 18
    • 0017808152 scopus 로고
    • Addition of reserpine to antipsychotic medication in refractory chronic schizophrenic outpatients
    • Bacher NM, Lewis HA. Addition of reserpine to antipsychotic medication in refractory chronic schizophrenic outpatients. Am J Psychiatry 1978; 135:488-489
    • (1978) Am J Psychiatry , vol.135 , pp. 488-489
    • Bacher, N.M.1    Lewis, H.A.2
  • 19
    • 0018971860 scopus 로고
    • Propranolol in chronic schizophrenia: A controlled study in neuroleptic treated patients
    • Lindstrom L, Persson E. Propranolol in chronic schizophrenia: a controlled study in neuroleptic treated patients. Br J Psychiatry 1980;137: 125-130
    • (1980) Br J Psychiatry , vol.137 , pp. 125-130
    • Lindstrom, L.1    Persson, E.2
  • 20
    • 0020549843 scopus 로고
    • Propranolol in schizophrenia: A double-blind, placebo-controlled trial of propranolol as an adjunct to neuroleptic medication
    • Pugh C, Steinert J, Priest R. Propranolol in schizophrenia: a double-blind, placebo-controlled trial of propranolol as an adjunct to neuroleptic medication. Br J Psychiatry 1983;143:151-155
    • (1983) Br J Psychiatry , vol.143 , pp. 151-155
    • Pugh, C.1    Steinert, J.2    Priest, R.3
  • 21
    • 0017697831 scopus 로고
    • Propranolol as an adjunct to the treatment of schizophrenia
    • Yorkston N, Zaki SA, Pitcher DR, et al. Propranolol as an adjunct to the treatment of schizophrenia. Lancet 1977;2:575-578
    • (1977) Lancet , vol.2 , pp. 575-578
    • Yorkston, N.1    Zaki, S.A.2    Pitcher, D.R.3
  • 22
    • 0023621979 scopus 로고
    • Lorazepam/haloperidol combination therapy in schizophrenia: A double-blind study
    • Altamura AC, Mauri MC, Mantero M, et al. Lorazepam/haloperidol combination therapy in schizophrenia: a double-blind study. Acta Psychiatr Scand 1987;76:702-706
    • (1987) Acta Psychiatr Scand , vol.76 , pp. 702-706
    • Altamura, A.C.1    Mauri, M.C.2    Mantero, M.3
  • 23
    • 0016815596 scopus 로고
    • Anxiety in schizophrenia: The responses to chlordiazepoxide in an intensive design study
    • Kellner R, Wilson RM, Mudawer MD, et al. Anxiety in schizophrenia: the responses to chlordiazepoxide in an intensive design study. Arch Gen Psychiatry 1975;32:1246-1254
    • (1975) Arch Gen Psychiatry , vol.32 , pp. 1246-1254
    • Kellner, R.1    Wilson, R.M.2    Mudawer, M.D.3
  • 24
    • 0020040551 scopus 로고
    • Carbamazepine in treatment of violent schizophrenics
    • Hakola HPA, Lauluma VA. Carbamazepine in treatment of violent schizophrenics [letter]. Lancet 1982;1:1358
    • (1982) Lancet , vol.1 , pp. 1358
    • Hakola, H.P.A.1    Lauluma, V.A.2
  • 25
    • 0021249353 scopus 로고
    • Carbamazepine and neuroleptics in the treatment of schizophrenia
    • Luchins B. Carbamazepine and neuroleptics in the treatment of schizophrenia. Psychopharmacol Bull 1984;20:569-571
    • (1984) Psychopharmacol Bull , vol.20 , pp. 569-571
    • Luchins, B.1
  • 26
    • 0020512131 scopus 로고
    • Carbamazepine as adjunctive treatment in nonepileptic chronic inpatients with EEG temporal lobe abnormalities
    • Neppe VM. Carbamazepine as adjunctive treatment in nonepileptic chronic inpatients with EEG temporal lobe abnormalities. J Clin Psychiatry 1983;44:326-331
    • (1983) J Clin Psychiatry , vol.44 , pp. 326-331
    • Neppe, V.M.1
  • 27
    • 0023812652 scopus 로고
    • Clozapine for the treatment-resistant schizophrenic: A double-blind comparison with chlorpromazine
    • Kane J, Honigfeld G, Singer J, et al. Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine. Arch Gen Psychiatry 1988;45:789-796
    • (1988) Arch Gen Psychiatry , vol.45 , pp. 789-796
    • Kane, J.1    Honigfeld, G.2    Singer, J.3
  • 28
    • 0024841558 scopus 로고
    • Acute treatment response and short term outcome in schizophrenia: First results of the NIMH treatment strategies in schizophrenia study. Treatment strategies in schizophrenia collaborative study group
    • Schooler NR, Keith SJ, Severe JB, et al. Acute treatment response and short term outcome in schizophrenia: first results of the NIMH treatment strategies in schizophrenia study. Treatment Strategies in Schizophrenia Collaborative Study Group. Psychopharmacol Bull 1989;5:331-335
    • (1989) Psychopharmacol Bull , vol.5 , pp. 331-335
    • Schooler, N.R.1    Keith, S.J.2    Severe, J.B.3
  • 29
    • 0025255494 scopus 로고
    • Change in haloperidol level due to carbamazepine: A complicating medication for schizophrenia
    • Kahn EM, Schulz SC, Perel JM, et al. Change in haloperidol level due to carbamazepine: a complicating medication for schizophrenia. J Clin Psychopharmacol 1990;10:54-57
    • (1990) J Clin Psychopharmacol , vol.10 , pp. 54-57
    • Kahn, E.M.1    Schulz, S.C.2    Perel, J.M.3
  • 30
    • 0017044625 scopus 로고
    • Adverse reactions in treatment with lithium carbonate and haloperidol
    • Baastrup PC, Hollnagel P, Sorensen R, et al. Adverse reactions in treatment with lithium carbonate and haloperidol. JAMA 1976;236:2645-2646
    • (1976) JAMA , vol.236 , pp. 2645-2646
    • Baastrup, P.C.1    Hollnagel, P.2    Sorensen, R.3
  • 31
    • 0019994882 scopus 로고
    • Neurotoxicity in patients with schizophrenia during lithium therapy
    • Prakash R, Kelwala S, Ban TA. Neurotoxicity in patients with schizophrenia during lithium therapy. Compr Psychiatry 1982;23:271-273
    • (1982) Compr Psychiatry , vol.23 , pp. 271-273
    • Prakash, R.1    Kelwala, S.2    Ban, T.A.3
  • 32
    • 0020371960 scopus 로고
    • Neurotoxicity with combined administration of lithium and a neuroleptic
    • Prakash R, Kelwala S, Ban TA. Neurotoxicity with combined administration of lithium and a neuroleptic. Compr Psychiatry 1982;23:567-571
    • (1982) Compr Psychiatry , vol.23 , pp. 567-571
    • Prakash, R.1    Kelwala, S.2    Ban, T.A.3
  • 33
    • 0023924694 scopus 로고
    • Alprazolam augmentation of the antipsychotic effects of fluphenazine in schizophrenic patients: Preliminary results
    • Wolkowitz OM, Breier A, Doran A, et al. Alprazolam augmentation of the antipsychotic effects of fluphenazine in schizophrenic patients: preliminary results. Arch Gen Psychiatry 1988;45:664-671
    • (1988) Arch Gen Psychiatry , vol.45 , pp. 664-671
    • Wolkowitz, O.M.1    Breier, A.2    Doran, A.3
  • 35
    • 0021363587 scopus 로고
    • Impact of lithium therapy on core psychotic symptoms of schizophrenia
    • Zemlan FP, Hirschowitz J, Sautter FJ, et al. Impact of lithium therapy on core psychotic symptoms of schizophrenia. Br J Psychiatry 1984;144: 64-69
    • (1984) Br J Psychiatry , vol.144 , pp. 64-69
    • Zemlan, F.P.1    Hirschowitz, J.2    Sautter, F.J.3
  • 36
    • 0015386388 scopus 로고
    • A comparison of lithium carbonate and chlorpromazine in the treatment of excited schizo-affectives: Report of the veterans administration and national institute of mental health collaborative study group
    • Prien RF, Caffey EM Jr, Klett CJ. A comparison of lithium carbonate and chlorpromazine in the treatment of excited schizo-affectives: report of the Veterans Administration and National Institute of Mental Health collaborative study group. Arch Gen Psychiatry 1972;27:182-189
    • (1972) Arch Gen Psychiatry , vol.27 , pp. 182-189
    • Prien, R.F.1    Caffey E.M., Jr.2    Klett, C.J.3
  • 37
    • 0015135942 scopus 로고
    • A controlled study of lithium vs chlorpromazine in acute schizophrenics
    • Shopsin B, Kim SS, Gershon S. A controlled study of lithium vs chlorpromazine in acute schizophrenics. Br J Psychiatry 1971;119:435-440
    • (1971) Br J Psychiatry , vol.119 , pp. 435-440
    • Shopsin, B.1    Kim, S.S.2    Gershon, S.3
  • 39
    • 0000503515 scopus 로고
    • The brief psychiatric rating scale
    • Overall JE, Gorman DR. The Brief Psychiatric Rating Scale. Psychol Rep 1962;10:799-812
    • (1962) Psychol Rep , vol.10 , pp. 799-812
    • Overall, J.E.1    Gorman, D.R.2
  • 41
    • 0003412410 scopus 로고
    • US Dept Health, Education, and Welfare publication (ADM) 76-338. Rockville, Md: National Institute of Mental Health
    • Guy W. ECDEU Assessment Manual for Psychopharmacology. US Dept Health, Education, and Welfare publication (ADM) 76-338. Rockville, Md: National Institute of Mental Health; 1976:218-222
    • (1976) ECDEU Assessment Manual for Psychopharmacology , pp. 218-222
    • Guy, W.1
  • 42
    • 0014723449 scopus 로고
    • A rating scale for extrapyramidal side effects
    • Simpson GM, Angus JWS. A rating scale for extrapyramidal side effects. Acta Psychiatr Scand Suppl 1970;45(suppl 212):11-19
    • (1970) Acta Psychiatr Scand Suppl , vol.45 , Issue.212 SUPPL. , pp. 11-19
    • Simpson, G.M.1    Angus, J.W.S.2
  • 43
    • 0022481698 scopus 로고
    • SAFTEE: A technique for the systematic assessment of side effects in clinical trials
    • Levine J, Schooler NR. SAFTEE: a technique for the systematic assessment of side effects in clinical trials. Psychopharmacol Bull 1986;22: 343-381
    • (1986) Psychopharmacol Bull , vol.22 , pp. 343-381
    • Levine, J.1    Schooler, N.R.2
  • 46
    • 0027152241 scopus 로고
    • Addition of lithium to haloperidol in non-affective, antipsychotic non-responsive schizophrenia: A double blind, placebo controlled, parallel design clinical trial
    • Wilson WH. Addition of lithium to haloperidol in non-affective, antipsychotic non-responsive schizophrenia: a double blind, placebo controlled, parallel design clinical trial. Psychopharmacology (Berl) 1993;111: 359-366
    • (1993) Psychopharmacology (Berl) , vol.111 , pp. 359-366
    • Wilson, W.H.1
  • 47
    • 0025768391 scopus 로고
    • Lithium carbonate in chronic schizophrenia: A brief trial of lithium carbonate added to neuroleptics for treatment of resistant schizophrenic patients
    • Collins PJ, Larkin EP, Shubsachs APW. Lithium carbonate in chronic schizophrenia: a brief trial of lithium carbonate added to neuroleptics for treatment of resistant schizophrenic patients. Acta Psychiatr Scand 1991; 84:150-154
    • (1991) Acta Psychiatr Scand , vol.84 , pp. 150-154
    • Collins, P.J.1    Larkin, E.P.2    Shubsachs, A.P.W.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.